(Click image to play video) Did you know that in Canada, it is estimated that by the age of 40, half of the population will have, or will have had, a mental illness? The recent surge of interest in psychedelic drugs is due to their potential for more effective tr...
Dave Jackson
|
May 10, 2021
|
We are already halfway through July and despite being in the midst of these sleepy summer days, both the business world and Bullboards have certainly picked up in activity. We track the most-viewed Bullboards in each sector every week and bring you some of...
Jonathon Brown
|
July 14, 2022
|
Relief for Bayer. In the U.S., the company has won a victory in the dispute over compensation for illnesses caused by the chemical PCB. Is it groundbreaking and the start of a revaluation of the stock? A revaluation already seems to be underway at Power Nickel. Follo...
Fabian Lorenz
|
7 days ago
|
Amgen shares are trading 5–6% higher today on news that the company has won its Enbrel (etanercept) patent court case. On Friday, August 9, 2019, Amgen Inc. (AMGN:NASDAQ) announced that it had won its Enbrel patent case. The company advised that the U.S. District C...
Streetwise Reports
|
August 14, 2019
|
Stock markets around the world are in recovery mode. Fear and panic over the spread of the corona virus is fading and greed is returning. COVID-19 has kept the world in suspense. After hesitant action by governments in Europe and North America, although curfews were imposed in...
Mario Hose
|
April 30, 2020
|
Shares of Stemline Therapeutics traded 150% higher after the company reported that it has entered into a definitive agreement to be acquired by Italy's Menarini Group in a deal valued at up to $677 million. Stemline Therapeutics Inc. (STML:NASDAQ) , which is...
Streetwise Reports
|
May 5, 2020
|
Shares of BeiGene Ltd. traded 35% higher today to a new a 52-week intraday high after announcing a commercialization agreement for of XGEVA (denosumab), KYPROLIS (carfilzomib), and BLINCYTO (blinatumomab) with Amgen Inc. in China. As part of the partnership, Amgen will invest ...
Streetwise Reports
|
November 4, 2019
|
Nestle SA (NESN:VX; NSRGY:OTC, Sfr 111.68) continues its pattern of consistent growth. In results for the first half (Nestle reports semi-annually, like most Swiss companies), underlying earnings per share increased almost 16% in constant currency, though reported earn...
Streetwise Reports
|
September 5, 2019
|
“Pandemic”. Few words in the English language conjure as much fear. The mere utterance evokes images of dying patients, surgical masks, haz-mat suits, a parade of coffins, helpless doctors and nurses, as the contagion spreads, first striking down the el...
Richard (Rick) Mills
|
February 25, 2020
|
As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...
Richard (Rick) Mills
|
April 24, 2020
|